Wyeth Is Warned on Quality Control at Plant
From Reuters
Possible contaminants in headache remedies, hormone replacement therapy and other pills made at Wyeth’s plant in Puerto Rico have not been adequately checked or corrected, the U.S. Food and Drug Administration said.
The warning came on top of a Merrill Lynch & Co. downgrade of Wyeth to “neutral†from “buy.†Wyeth shares fell $1.55 to $46.32.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
